CLDX — Celldex Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Celldex Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	64.4	194	408	305	424
Net Total Accounts Receivable
Net Total Receivables	1.01	1.8	0.172	0.347	2.63
Prepaid Expenses
Total Current Assets	66.7	198	411	318	432
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.5	7.26	6.52	7.75	6.64
Net Intangible Assets
Other Long Term Assets
Total Assets	123	236	445	353	466
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	11.6	14.2	16.5	18.6	31.1
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	28.9	26.5	25.2	26.5	36.5
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	94	209	419	326	429
Total Liabilities & Shareholders' Equity	123	236	445	353	466
Total Common Shares Outstanding